Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 969-973

  Loprinzi, C L ^a   Abu Ghazaleh, S ^a   Sloan, J A ^a   vanHaelst Pisani, C ^a   Hammer, A M ^a   Rowland Jr , K M ^a   Law, M ^a   Windschitl, H E ^a   Kaur, J S ^a   Ellison, N ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; LUBRICATING AGENT; PLACEBO; POLYCARBOPHIL; REPLENS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPAREUNIA; ESTROGEN DEFICIENCY; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; LUBRICATION; MOISTURE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VAGINA DISEASE; XEROSIS;

EID: 0031056943     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.969     Document Type: Article

References (12)

1. Mishell DR (ed): Menopause: Physiology and Pharmacology. Chicago, IL, Year Book, 1988
2. Semmens JP, Gorm W: Estrogen deprivation and vaginal function in postmenopausal women. JAMA 248:445-448, 1982
3. Key TJA, Pike MCI: The role of estrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24:29-43, 1988
4. Bergkvist L, Adami H-O, Persson I, et al: The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:293-297, 1989
5. Young RL, Kumar NS, Goldzieher JW: Management of menopause when estrogen cannot be used. Drugs 40:220-230, 1990
6. Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103-115, 1975
7. Senn S: Cross-Over Trials in Clinical Research. New York, NY, Wiley, 1993
8. Bachmann GA, Notelovitz M, Kelly SJ, et al: Long term non-hormonal treatment of vaginal dryness. Clin Pract Sex 8:3-8, 1992
9. Nachtigall LE: Comparative study: Replens versus local estrogen in menopausal women. Fert Steril 61:178-180, 1994
10. Bygdeman M, Swahn ML: Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 23:259-263, 1996
11. Ganz PA, Rowland J, Meyerowitz B, et al: Breast cancer survivors (BCS): Sexuality and intimacy concerns. Breast Cancer Res Treat 37:35, 1996 (suppl; abstr)
12. Couzi RJ, Helslsouer KJ, Fetting JH: Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 13:2737-2744, 1995